IONIS PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2010 to Q3 2024.
  • Ionis Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $32M, a 23.2% increase year-over-year.
  • Ionis Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $120M, a 14.5% increase year-over-year.
  • Ionis Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $106M, a 5.53% increase from 2022.
  • Ionis Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $100M, a 16.9% decline from 2021.
  • Ionis Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $121M, a 47.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $120M $32M +$6.02M +23.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $114M $30.7M +$4.17M +15.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $110M $31.3M +$4.39M +16.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $106M $26.3M +$647K +2.52% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $105M $26M +$2.13M +8.92% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $103M $26.6M +$2.06M +8.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $101M $26.9M +$712K +2.71% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $100M $25.7M +$3.43M +15.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $96.8M $23.8M -$6.7M -21.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $104M $24.5M -$5.52M -18.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $109M $26.2M -$11.6M -30.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $121M $22.3M -$72.8M -76.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $193M $30.5M -$15.3M -33.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $209M $30M -$18.4M -38% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $227M $37.9M -$2.93M -7.18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $230M $95M +$60M +171% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $170M $45.8M +$21.7M +90% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $148M $48.4M +$6.51M +15.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $142M $40.8M -$4.72M -10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $147M $35M +$908K +2.66% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $146M $24.1M -$10.8M -30.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $156M $41.9M +$8.06M +23.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $148M $45.5M +$17.1M +59.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $131M $34.1M +$11.8M +52.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $120M $34.9M +$13.4M +62.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $106M $33.9M +$12.6M +59.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $93.5M $28.5M +$7.54M +36.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $86M $22.3M +$7.17M +47.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $78.8M $21.5M +$3.89M +22.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $74.9M $21.3M +$2M +10.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $72.9M $20.9M +$809K +4.02% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $72.1M $15.2M -$2.25M -12.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $74.4M $17.6M +$2.59M +17.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $71.8M $19.3M +$5.66M +41.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $66.1M $20.1M +$6.8M +51.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $59.3M $17.4M +$8.92M +105% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $50.4M $15M +$6.88M +84.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $43.5M $13.6M +$5.9M +76.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $37.6M $13.3M +$6.24M +88.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $31.4M $8.49M +$5.39M +174% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $26M $8.12M +$5.31M +189% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $20.7M $7.71M +$5.07M +192% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $15.6M $7.07M +$4.2M +146% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $11.4M $3.1M +$1.29M +71.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $10.1M $2.81M +$778K +38.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $9.35M $2.64M +$176K +7.15% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $9.17M $2.87M +$602K +26.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 $8.57M $1.81M -$439K -19.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $9.01M $2.03M -$330K -14% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $9.34M $2.46M -$40K -1.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $9.38M $2.27M -$465K -17% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 $9.85M $2.25M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $2.36M -$596K -20.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $2.5M -$632K -20.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $2.73M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $2.96M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $3.13M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.